QuidelOrtho to Report Second Quarter 2024 Financial Results

Rhea-AI Summary

QuidelOrtho (Nasdaq: QDEL), a global provider of innovative in vitro diagnostic technologies, has announced that it will report its financial results for the second quarter of 2024 on Wednesday, July 31, 2024, after the market close. The company will hold a conference call at 2:00 p.m. PT / 5:00 p.m. ET to discuss the results.

Interested parties can access the call through the 'Events & Presentations' section of QuidelOrtho's Investor Relations webpage. Presentation materials will be posted at the time of the call. Those unable to access the webcast can join via phone by dialing 833-470-1428 (domestic) or +1 929-526-1599 (international) with Conference ID 533267. A replay of the call will be available on the company's website shortly after the event.

SAN DIEGO--(BUSINESS WIRE)-- QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that it will report its financial results for its second quarter 2024 ended June 30, 2024, after the market close on Wednesday, July 31, 2024.

Following the release of financial results, QuidelOrtho will hold a conference call beginning at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial results. Interested parties can access the call on the “Events & Presentations” section of the “Investor Relations” page of the Company’s website at https://ir.quidelortho.com/. Presentation materials will also be posted to the “Events & Presentations” section of the “Investor Relations” page of the Company’s website at the time of the call. Those unable to access the webcast may join the call via phone by dialing 833-470-1428 (domestic) or +1 929-526-1599 (international) and entering Conference ID number 533267.

A replay of the conference call will be available shortly after the event on the “Investor Relations” page of the Company’s website under the “Events & Presentations” section.

About QuidelOrtho Corporation

QuidelOrtho Corporation (Nasdaq: QDEL) is a world leader in in vitro diagnostics, developing and manufacturing intelligent solutions that transform data into understanding and action for more people in more places every day.

Offering industry-leading expertise in immunoassay and molecular testing, clinical chemistry and transfusion medicine, bringing fast, accurate and reliable diagnostics when and where they are needed – from home to hospital, lab to clinic. So that patients, clinicians and health officials can spot trends sooner, respond quicker and chart the course ahead with accuracy and confidence.

Building upon its many years of groundbreaking innovation, QuidelOrtho continues to partner with customers across the healthcare continuum and around the globe to forge a new diagnostic frontier. One where insights and solutions know no bounds, expertise seamlessly connects and a more informed path is illuminated for each of us.

QuidelOrtho is advancing diagnostics to power a healthier future.

For more information, please visit www.quidelortho.com.

Source: QuidelOrtho Corporation

View source version on businesswire.com: https://www.businesswire.com/news/home/20240717201270/en/

Investor Contact:

Juliet Cunningham

Vice President, Investor Relations

IR@quidelortho.com

Media Contact:

D. Nikki Wheeler

Senior Director, Corporate Communications

media@QuidelOrtho.com

Source: QuidelOrtho Corporation

FAQ

When will QuidelOrtho (QDEL) report its Q2 2024 financial results?

QuidelOrtho (QDEL) will report its Q2 2024 financial results on Wednesday, July 31, 2024, after the market close.

What time is QuidelOrtho's (QDEL) Q2 2024 earnings conference call?

QuidelOrtho's (QDEL) Q2 2024 earnings conference call is scheduled for 2:00 p.m. PT / 5:00 p.m. ET on Wednesday, July 31, 2024.

How can investors access QuidelOrtho's (QDEL) Q2 2024 earnings call?

Investors can access QuidelOrtho's (QDEL) Q2 2024 earnings call through the 'Events & Presentations' section of the company's Investor Relations webpage or by dialing 833-470-1428 (domestic) or +1 929-526-1599 (international) with Conference ID 533267.

Will QuidelOrtho (QDEL) provide presentation materials for its Q2 2024 earnings call?

Yes, QuidelOrtho (QDEL) will post presentation materials for its Q2 2024 earnings call on the 'Events & Presentations' section of its Investor Relations webpage at the time of the call.